Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease

Genes and Immunity

Volumn 2, Issue 7, 2001, Pages 357-362

  Sohn, M H ^a   Hur, M W ^a   Kim, D S ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

IL 6, promoter; Kawasaki disease; Polymorphism

Indexed keywords

INTERLEUKIN 6;

ACUTE DISEASE; ANIMAL; ARTICLE; BLOOD; CELL LINE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROMOTER REGION; REPORTER GENE; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION;

ACUTE DISEASE; ANIMALS; BASE SEQUENCE; CELL LINE; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, REPORTER; GENETIC PREDISPOSITION TO DISEASE; HELA CELLS; HUMANS; INFANT; INTERLEUKIN-6; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUTAGENESIS, SITE-DIRECTED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 0035511797     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363785     Document Type: Article

References (24)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: Clinical observations of 50 cases. Jpn J Allerg 1967; 16: 178-222.
2. Kawasaki T, Kosaki F, Osawa S, Shigematsu I, Yanagawa S. A new infantile acute febrile mucocutaneous lymphnode syndrome (MCLS) prevailing in Japan. Pediatrics 1974; 54: 271-276.
3. Leung DYM, Chu ET, Wood N, Grady S, Meade R, Gdha R. Immunoregulatory T cell abnormalities in MCLS. J Immunol 1983; 130: 2002-2004.
4. Furukawa S, Matsubara T, Jujho K et al. Peripheral blood monocyte macrophage and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988; 48: 247-251.
5. Furukawa S, Matsubara T, Motohashi T, Nakachi S, Sasai K, Yabuta K. Expression of FcεR2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Clin Immunol Immunopathol 1990; 56: 280-286.
6. Laxer RL, Schffer FL, Myones B et al. Lymphocyte abnormalities and complement activation in Kawasaki disease. Prog Clin Biol Res 1987; 250: 175-184.
7. Kim DS, Han BH, Lee SK, Lee HK, Chaw YJ, Lee KY. Evidence for selection of 11 amino acid CDR3 domains in VκIII-derived immunoglobulin light chains in Kawasaki disease. Scand J Rheumatol 1997; 26: 350-354.
8. Kim DS, Hwang HY, Yu CJ. Oligoclonal expansion of the VH family in Kawasaki disease. J Korean Pediatr Soc 1999; 42: 1246-1254.
9. Lang BA, Silveramn ED, Laxer RM, Lau AS. Spontaneous tumor necrosis factor production in Kawasaki disease. J Pediatr 1989; 115: 939-943.
10. Maury CPJ, Salo E, Pelkonen D. Circulating interleukin-1β in patients with Kawasaki disease. N Engl J Med 1988; 319: 1670-1671.
11. Kim DS. Serum interleukin-6 in Kawasaki disease. Yonsei Med J 1992; 33: 183-188.
12. Ueno Y, Takano N, Kanegane H et al. The acute phase nature of interleukin-6: studies in Kawasaki disease and other febrile illness. Clin Exp Immunol 1989; 76: 337-342.
13. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin-6. Immunol Today 1990; 11: 443-449.
14. Kim MK, Kim DS. The interleukin-6 level in Kawasaki disease. J Korean Pediatr Soc 1992; 35: 515-525.
15. Olomolaiye OO, Wood NAP, Bidwell JL. A novel NlaIII polymorphism in the human IL-6 promoter. Eur J Immunogen 1998; 25: 267-268.
16. Faulds G, Fishman D, Woo P, Humphries S. Novel FokI polymorphism in the 5′ flanking region of the human IL-6 gene. Genbank/EMBL, Accession number AF048692.
17. Nakajima T, Ota N, Yoshida H, Watanabe S, Suzuki T, Emi M. Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1999; 1: 115-119.
18. Osiri M, McNicholl J, Moreland LW, Bridges SL Jr. A novel single nucleotide polymorphism and five probable haplotypes in the 5′ flanking region of the IL-6 gene in African-Americans. Genes Immun 1999; 1: 166-167.
19. Jordanides N, Eskdale J, Stuart R, Gallagher G. Allele associations reveal four prominent haplotypes at the human interleukin-6 (IL-6) locus. Genes Immun 2000; 1: 451-455.
20. Linker-Israeli M, Wallace DJ, Prehn JL, Nand R, Li L, Klinenberg JR. A great variability in the 3′ flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE). Autoimmunity 1996; 23: 199-209.
21. Papassotiropoulos A, Bagli M, Jessen F et al. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann Neurol 1999; 45: 666-668.
22. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
23. Collado-Escobar MD, Nieto A, Mataran L, Raya E, Martin J. Interleukin 6 gene polymorphism in not associated with ankylosing spondylitis. J Rheumatol 2000; 27: 1461-1463.
24. Mason WH, Takahashi M. Kawasaki syndrome. Clin Infect Dis 1999; 28: 169-187.